Stay updated with breaking news from Lobe Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company Exploring Alternative Value Creation Opportunities Convertible note for $500,000.00 USD, Short-term Debt Reduced and Balance Sheet Strengthened to Prepare the Company for Long Term Funding...
04.06.2024 - Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ('Lobe' or the 'Company'), a biopharmaceutical company focused on developing transformative medicines to treat diseases with unmet medical needs and rare diseases announced the evaluation of strategic ... Seite 1
Providing a Proven Track Record of Driving Growth and Innovation ...
Lobe Sciences (TSE:LOBE) has released an update. Lobe Sciences Ltd., a biopharmaceutical company, has announced a change of control after Clearway ...
Lobe Sciences Ltd. , a biopharmaceutical company focused on developing transformative medicines to treat rare diseases and Clearway Global, LLC , a wholly owned subsidiary of Sancilio & Company , a...